MP
ABBV icon

McDonald Partners’s AbbVie ABBV Stock Holding History

McDonald Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.24M Sell
20,808
-19,585
-48% -$4.21M 1.27% 15
2026
Q1 		$8.79M Buy
40,393
+20,426
+102% +$4.53M 2.07% 7
2025
Q4 		$4.56M Buy
19,967
+378
+2% +$86.1K 1.44% 16
2025
Q3 		$4.54M Sell
19,589
-3,327
-15% -$678K 1.35% 15
2025
Q2 		$4.25M Buy
22,916
+295
+1% +$54.8K 1.02% 24
2025
Q1 		$4.74M Sell
22,621
-1,331
-6% -$259K 1.23% 14
2024
Q4 		$4.26M Buy
23,952
+1,874
+8% +$345K 1.09% 20
2024
Q3 		$4.36M Sell
22,078
-2,392
-10% -$446K 1.09% 21
2024
Q2 		$4.2M Buy
24,470
+1,093
+5% +$181K 1.12% 21
2024
Q1 		$4.26M Buy
23,377
+898
+4% +$155K 1.17% 18
2023
Q4 		$3.48M Buy
22,479
+96
+0.4% +$14K 1.03% 23
2023
Q3 		$3.34M Buy
22,383
+3,192
+17% +$469K 1.09% 22
2023
Q2 		$2.59M Buy
19,191
+1,737
+10% +$255K 0.79% 35
2023
Q1 		$2.78M Buy
17,454
+691
+4% +$106K 0.9% 31
2022
Q4 		$2.71M Sell
16,763
-649
-4% -$99.5K 0.93% 29
2022
Q3 		$2.34M Sell
17,412
-757
-4% -$109K 0.89% 29
2022
Q2 		$2.78M Sell
18,169
-381
-2% -$58.2K 0.71% 36
2022
Q1 		$3.01M Buy
18,550
+18,494
+33,025% +$2.69M 0.66% 39
2021
Q4 		$7.58K Sell
56
-16,626
-100% -$1.96M 0.01% 209
2021
Q3 		$1.8M Buy
16,682
+462
+3% +$52.8K 0.42% 66
2021
Q2 		$1.83M Buy
16,220
+103
+0.6% +$11.6K 0.43% 67
2021
Q1 		$1.74M Buy
16,117
+162
+1% +$17.3K 0.45% 66
2020
Q4 		$1.71M Buy
+15,955
New +$1.53M 0.48% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

McDonald Partners's ABBV Position: Q2 2026 in Review

McDonald Partners reduced its AbbVie (ABBV) stake by 48% in Q2 2026, selling an estimated $4.21M and leaving 20,808 shares worth $5.24M. The position accounts for 1.27% of the portfolio, ranked #15.

McDonald Partners first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.79M in Q1 2026. 4,214 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • McDonald Partners held 20,808 shares of AbbVie worth $5.24M as of Q2 2026.
  • McDonald Partners sold 19,585 AbbVie shares in Q2 2026, an estimated $4.21M.
  • AbbVie made up 1.27% of McDonald Partners's portfolio in Q2 2026, its #15 holding.
  • McDonald Partners first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • McDonald Partners's AbbVie position peaked at $8.79M in Q1 2026.
  • 4,214 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on McDonald Partners's 13F filing for Q2 2026, filed 28 Jul 2026.